BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29622276)

  • 1. Prospective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration.
    Armbruster SD; Sun CC; Westin SN; Bodurka DC; Ramondetta L; Meyer LA; Soliman PT
    Gynecol Oncol; 2018 Jun; 149(3):484-490. PubMed ID: 29622276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of quality of life in patients undergoing pelvic exenteration: interim results.
    Rezk YA; Hurley KE; Carter J; Dao F; Bochner BH; Aubey JJ; Caceres A; Einstein MH; Abu-Rustum NR; Barakat RR; Makker V; Chi DS
    Gynecol Oncol; 2013 Feb; 128(2):191-7. PubMed ID: 23063761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Assessment of First-Year Quality of Life After Pelvic Exenteration for Gynecologic Malignancy: A French Multicentric Study.
    Martinez A; Filleron T; Rouanet P; Méeus P; Lambaudie E; Classe JM; Foucher F; Narducci F; Gouy S; Guyon F; Marchal F; Jouve E; Colombo PE; Mourregot A; Rivoire M; Chopin N; Houvenaeghel G; Jaffre I; Leveque J; Lavoue V; Leblanc E; Morice P; Stoeckle E; Verheaghe JL; Querleu D; Ferron G
    Ann Surg Oncol; 2018 Feb; 25(2):535-541. PubMed ID: 29159738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life after pelvic exenteration for gynecologic cancer: Findings from a qualitative study.
    Nelson AM; Albizu-Jacob A; Fenech AL; Chon HS; Wenham RM; Donovan KA
    Psychooncology; 2018 Oct; 27(10):2357-2362. PubMed ID: 29956389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of Life in Women After Pelvic Exenteration for Gynecological Malignancies: A Multicentric Study.
    Dessole M; Petrillo M; Lucidi A; Naldini A; Rossi M; De Iaco P; Marnitz S; Sehouli J; Scambia G; Chiantera V
    Int J Gynecol Cancer; 2018 Feb; 28(2):267-273. PubMed ID: 26807639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of postoperative complications and quality of life between patients undergoing continent versus non-continent urinary diversion after pelvic exenteration for gynecologic malignancies.
    Angeles MA; Mallet E; Rouanet P; Cabarrou B; Méeus P; Lambaudie E; Foucher F; Narducci F; Loaec C; Gouy S; Guyon F; Marchal F; Gladieff L; Martínez-Gómez C; Migliorelli F; Martinez A; Ferron G
    Int J Gynecol Cancer; 2020 Feb; 30(2):233-240. PubMed ID: 31796531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in quality of life after robotic surgery results in patient satisfaction.
    Arms RG; Sun CC; Burzawa JK; Fleming ND; Nick AM; Rallapalli V; Westin SN; Meyer LA; Ramirez PT; Soliman PT
    Gynecol Oncol; 2015 Sep; 138(3):727-30. PubMed ID: 26197762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life after pelvic exenteration.
    Roos EJ; de Graeff A; van Eijkeren MA; Boon TA; Heintz AP
    Gynecol Oncol; 2004 Jun; 93(3):610-4. PubMed ID: 15196852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal reconstruction at the time of pelvic exenteration: a surgical and psychosexual analysis of techniques.
    Mirhashemi R; Averette HE; Lambrou N; Penalver MA; Mendez L; Ghurani G; Salom E
    Gynecol Oncol; 2002 Oct; 87(1):39-45. PubMed ID: 12468340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
    Jäger L; Nilsson PJ; Rådestad AF
    Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of tumor size on outcomes following pelvic exenteration.
    Smith B; Jones EL; Kitano M; Gleisner AL; Lyell NJ; Cheng G; McCarter MD; Abdel-Misih S; Backes FJ
    Gynecol Oncol; 2017 Nov; 147(2):345-350. PubMed ID: 28822555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilising quality of life outcome trajectories to aid patient decision making in pelvic exenteration.
    Harji DP; Williams A; McKigney N; Boissieras L; Denost Q; Fearnhead NS; Jenkins JT; Griffiths B
    Eur J Surg Oncol; 2022 Nov; 48(11):2238-2249. PubMed ID: 36030134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic Exenteration in Advanced Gynecologic Malignancies - Who Will Benefit?
    Egger EK; Liesenfeld H; Stope MB; Recker F; Döser A; Könsgen D; Marinova M; Hilbert T; Exner D; Ellinger J; Mustea A
    Anticancer Res; 2021 Jun; 41(6):3037-3043. PubMed ID: 34083295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life.
    Quyn AJ; Austin KK; Young JM; Badgery-Parker T; Masya LM; Roberts R; Solomon MJ
    Eur J Surg Oncol; 2016 Jun; 42(6):823-8. PubMed ID: 26947962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief report: total pelvic exenteration--A retrospective clinical needs assessment.
    Carter J; Chi DS; Abu-Rustum N; Brown CL; McCreath W; Barakat RR
    Psychooncology; 2004 Feb; 13(2):125-31. PubMed ID: 14872531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term outcomes following pelvic exenteration for gynae-oncological and colorectal cancers: A 9 year consecutive single-centre cohort study.
    Katory M; McLean R; Paez E; Kucukmetin A; Naik R
    Int J Surg; 2017 Jul; 43():38-45. PubMed ID: 28529192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic exenterations for gynecological malignancies: a study of 36 cases.
    Kaur M; Joniau S; D'Hoore A; Van Calster B; Van Limbergen E; Leunen K; Penninckx F; Van Poppel H; Amant F; Vergote I
    Int J Gynecol Cancer; 2012 Jun; 22(5):889-96. PubMed ID: 22617477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic genital cancer: body image and sexuality.
    Sewell HH; Edwards DW
    Front Radiat Ther Oncol; 1979; 14():35-41. PubMed ID: 551010
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of treatment for genital cancer on quality of life and body image--results of a prospective longitudinal 10-year study.
    Hawighorst-Knapstein S; Fusshoeller C; Franz C; Trautmann K; Schmidt M; Pilch H; Schoenefuss G; Knapstein PG; Koelbl H; Kelleher DK; Vaupel P
    Gynecol Oncol; 2004 Aug; 94(2):398-403. PubMed ID: 15297179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort.
    Straubhar AM; Chi AJ; Zhou QC; Iasonos A; Filippova OT; Leitao MM; Awowole IO; Abu-Rustum NR; Broach VA; Jewell EL; Sandhu JS; Sonoda Y
    Gynecol Oncol; 2021 Nov; 163(2):294-298. PubMed ID: 34518053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.